Industries > Pharma > Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029

Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services

PUBLISHED: 30 August 2019
PAGES: 224
PRODUCT CODE: PHA0521
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0521 Categories: , Tags: ,

The Pre-Filled Device Manufacturing market is estimated to reach $8.3bn in 2024, growing at a CAGR of 9.5% throughout the forecast period.

The majority of revenues for pre-filled syringe manufacturers, including component manufacturers and pen injector/autoinjector manufacturers, came from developed markets.

How this 224-page report delivers:

• Provides an overview and revenue forecasts of the global pre-filled injectable devices market from 2019 to 2029

• Profiles of selected leading companies in the pre-filled injection device manufacturing:
• Leading pre-filled syringe manufacturers
• Leading pre-filled injectable component manufacturers
• Leading pen injector and autoinjector manufacturers
• Leading pre-filled injectable devices contract manufacturers

• Companies profiled in this report:
• Aptar Stelmi
• Becton, Dickinson, & Co (BD)
• Bespak Injectables
• Boehringer Ingelheim
• Catalent
• Dätwyler Holding
• Gerresheimer
• Haselmeier
• Laboratorios Farmacéuticos ROVI
• Nemera.
• Nipro
• Ompi
• Owen Mumford
• Roselabs Group.
• Schott
• SHL Group
• Tip-top
• Vetter Pharma
• Weigao Group Pharmaceutical Packaging Products Company
• West Pharmaceutical Services.
• Ypsomed

Top Pre-Filled Injection Device Manufacturers 2019-2029

• Information provided for the selected leading companies, when available:
• Overview of the company
• Historical Revenues
• Revenue forecasts from 2019-2029
• A SWOT analysis
• A competitive analysis
• Products & Services
• Business Developments: Expansion, new products, mergers, acquisitions, collaborations.

• This report also discusses the key trends in the pre-filled injection device manufacturing market.

109 charts unavailable elsewhere

Visiongain’s study is intended for anyone requiring commercial analyses for the pre-filled injection device manufacturing market. You find data, trends and predictions.

Buy our report today Top Pre-Filled Injection Device Manufacturers 2019-2029: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2019-2029


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category